| The role of astrocytes in multiple sclerosis G Ponath, C Park, D Pitt Frontiers in immunology 9, 217, 2018 | 374 | 2018 |
| Quantitative susceptibility mapping identifies inflammation in a subset of chronic multiple sclerosis lesions UW Kaunzner, Y Kang, S Zhang, E Morris, Y Yao, S Pandya, ... Brain 142 (1), 133-145, 2019 | 203 | 2019 |
| Enhanced astrocyte responses are driven by a genetic risk allele associated with multiple sclerosis G Ponath, MR Lincoln, M Levine-Ritterman, C Park, S Dahlawi, ... Nature communications 9 (1), 5337, 2018 | 80 | 2018 |
| Multiplexed imaging of immune cells in staged multiple sclerosis lesions by mass cytometry V Ramaglia, S Sheikh-Mohamed, K Legg, C Park, OL Rojas, S Zandee, ... Elife 8, e48051, 2019 | 71 | 2019 |
| QSM is an imaging biomarker for chronic glial activation in multiple sclerosis lesions KM Gillen, M Mubarak, C Park, G Ponath, S Zhang, A Dimov, ... annals of Clinical and Translational Neurology 8 (4), 877-886, 2021 | 70 | 2021 |
| The landscape of myeloid and astrocyte phenotypes in acute multiple sclerosis lesions C Park, G Ponath, M Levine-Ritterman, E Bull, EC Swanson, PL De Jager, ... Acta neuropathologica communications 7, 1-13, 2019 | 54 | 2019 |
| Differential expression of the T-cell inhibitor TIGIT in glioblastoma and MS LE Lucca, BA Lerner, C Park, D DeBartolo, B Harnett, VP Kumar, ... Neurology: Neuroimmunology & Neuroinflammation 7 (3), e712, 2020 | 38 | 2020 |
| The TIGIT/CD226/CD155 axis is differentially expressed in MS and glioblastoma: implications for autoimmunity and tumor immune escape.(P4. 043) D Lowther, S Ramanan, D DeBartolo, C Park, X Duan, D Hafler, D Pitt Neurology 84 (14_supplement), P4. 043, 2015 | 4 | 2015 |
| Astrocytes in neuroinflammatory and neurodegenerative diseases S Bhandarkar, D Qavi, C Park, D Pitt Elsevier, 2023 | 1 | 2023 |
| Immune infiltrates expressing podoplanin (PDPN) are present in multiple sclerosis but not glioblastoma (S12. 002) A Nylander, S Ramanan, D Debartolo, C Park, D Hafler, D Pitt Neurology 84 (14_supplement), S12. 002, 2015 | 1 | 2015 |
| ELIZABETHKINGIA MENINGOSEPTICA PNEUMONIA AND BACTEREMIA IN AN ELDERLY, IMMUNOCOMPROMISED FARMER C PARK, A MEHTA, E CAPOZZA, F TROPEA, K ESKANDER, ... CHEST 166 (4), A1048-A1049, 2024 | | 2024 |
| CNS cell-derived exosome signatures as blood-based biomarkers of neurodegenerative diseases C Park, JS Weerakkody, R Schneider, S Miao, D Pitt Frontiers in Neuroscience 18, 1426700, 2024 | | 2024 |
| Adenosine (2A) Receptor Expression in Progressive MS is Associated with Astroglial Pan-activation and High Oxidative Toxicity CH Lo, G Ponath, S Toro, S Bhandarkar, M Mansoor, C Park, L Airas, ... MULTIPLE SCLEROSIS JOURNAL 27 (1_ SUPPL), 10-10, 2021 | | 2021 |
| Multiplex Imaging of Immune Cells in the Multiple Sclerosis Brain (4485) V Ramaglia, S Sheikh-Mohamed, K Legg, C Park, O Rojas, S Zandee, ... Neurology 94 (15_supplement), 4485, 2020 | | 2020 |
| Differential Expression of the T cell Inhibitor TIGIT in Glioblastoma and Multiple Sclerosis LE Lucca, BA Lerner, D DeBartolo, C Park, G Ponath, K Raddassi, ... bioRxiv, 591131, 2019 | | 2019 |
| Highly-Multiplexed Imaging of MS Lesions Reveals Multiple Functional Immune Cell Phenotypes and Specific Cell-Cell Interactions C Park, M Levine-Ritterman, E Bull, G Ponath, E Swanson, D Pitt ACTRIMS Forum 2019, 2019 | | 2019 |
| Adenosine A2a Receptor Signaling in Reactive Astrocytes Increases Oxidative Damage in Progressive Multiple Sclerosis G Ponath, C Park, M Levine-Ritterman, L Airas, D Pitt ACTRIMS Forum 2019, 2019 | | 2019 |
